Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 6:42 pm Purchase | 2025-09-30 | 13G | FG Nexus Inc. FGNX | Armistice Capital, LLC | 3,884,568 9.990% | 3,884,568 (New Position) | Filing History |
| 2025-11-14 6:41 pm Purchase | 2025-09-30 | 13G | Kyntra Bio, Inc. KYNB | Armistice Capital, LLC | 378,000 9.350% | 378,000 (New Position) | Filing History |
| 2025-11-14 6:41 pm Purchase | 2025-09-30 | 13G | Citius Oncology, Inc. CTOR | Armistice Capital, LLC | 7,675,911 9.790% | 7,675,911 (New Position) | Filing History |
| 2025-11-14 6:40 pm Sale | 2025-09-30 | 13G | Bio-Path Holdings, Inc. BPTH | Armistice Capital, LLC | 30,177 4.990% | -530,971 (-94.62%) | Filing History |
| 2025-11-14 6:39 pm Purchase | 2025-09-30 | 13G | Avanos Medical, Inc. AVNS | Armistice Capital, LLC | 2,500,000 5.390% | 2,500,000 (New Position) | Filing History |
| 2025-11-14 6:38 pm Purchase | 2025-09-30 | 13G | Autolus Therapeutics plc AUTL | Armistice Capital, LLC | 15,600,000 5.860% | 11,750,000 (+305.19%) | Filing History |
| 2025-11-14 6:38 pm Purchase | 2025-09-30 | 13G | Actelis Networks, Inc. ASNS | Armistice Capital, LLC | 90,160 5.790% | 58,553 (+185.26%) | Filing History |
| 2025-11-14 6:37 pm Sale | 2025-09-30 | 13G | Sphere 3D Corp. ANY | Armistice Capital, LLC | 1,771,482 4.990% | -889,263 (-33.42%) | Filing History |
| 2025-11-14 6:36 pm Sale | 2025-09-30 | 13G | Allurion Technologies Inc. ALUR | Armistice Capital, LLC | 136,486 4.990% | -48,514 (-26.22%) | Filing History |
| 2025-11-14 6:36 pm Purchase | 2025-09-30 | 13G | Aditxt, Inc. ADTX | Armistice Capital, LLC | 83,233 4.990% | 57,410 (+222.32%) | Filing History |
| 2025-11-14 6:34 pm Unchanged | 2025-09-30 | 13G | KINETA INC KANT | Armistice Capital, LLC | 1,823,138 3.640% | 0 (Unchanged) | Filing History |
| 2025-11-14 6:34 pm Sale | 2025-09-30 | 13G | Ekso Bionics Holdings, Inc. EKSO | Armistice Capital, LLC | 92,924 4.990% | -1,520,636 (-94.24%) | Filing History |
| 2025-11-14 6:33 pm Sale | 2025-09-30 | 13G | Immunic, Inc. IMUX | Armistice Capital, LLC | 372,085 4.990% | -56,458 (-13.17%) | Filing History |
| 2025-11-14 6:31 pm Sale | 2025-09-30 | 13G | Orthofix Medical Inc. OFIX | Armistice Capital, LLC | 2,236,000 5.650% | -728,000 (-24.56%) | Filing History |
| 2025-11-14 6:30 pm Sale | 2025-09-30 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 4,200,000 7.570% | -1,236,000 (-22.74%) | Filing History |
| 2025-11-14 6:29 pm Purchase | 2025-09-30 | 13G | Verrica Pharmaceuticals Inc. VRCA | Armistice Capital, LLC | 639,193 6.770% | 639,193 (New Position) | Filing History |
| 2025-11-14 6:29 pm Sale | 2025-09-30 | 13G | VolitionRx Limited VNRX | Armistice Capital, LLC | 9,380,425 8.720% | -423,927 (-4.32%) | Filing History |
| 2025-11-14 6:28 pm Sale | 2025-09-30 | 13G | Travere Therapeutics, Inc. TVTX | Armistice Capital, LLC | 6,724,000 7.520% | -2,148,000 (-24.21%) | Filing History |
| 2025-11-14 6:27 pm Purchase | 2025-09-30 | 13G | Treace Medical Concepts, Inc. TMCI | Armistice Capital, LLC | 6,316,000 9.990% | 105,000 (+1.69%) | Filing History |
| 2025-11-14 6:27 pm Sale | 2025-09-30 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 2,836,000 5.060% | -2,360,000 (-45.42%) | Filing History |